Idorsia Ltd (OTCMKTS:IDRSF) Short Interest Down 7.6% in March

Idorsia Ltd (OTCMKTS:IDRSF) was the target of a large drop in short interest during the month of March. As of March 31st, there was short interest totalling 8,420,100 shares, a drop of 7.6% from the March 15th total of 9,112,700 shares. Based on an average daily trading volume, of 6,500 shares, the short-interest ratio is presently 1,295.4 days.

Idorsia Stock Performance

Idorsia stock opened at $2.03 on Wednesday. Idorsia has a fifty-two week low of $1.40 and a fifty-two week high of $10.70. The firm has a 50 day moving average price of $2.03 and a 200 day moving average price of $2.16.

About Idorsia

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.